These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 8702661
21. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells. Fribourg AF, Knudsen KE, Strobeck MW, Lindhorst CM, Knudsen ES. Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590 [Abstract] [Full Text] [Related]
22. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression. Keenan SM, Lents NH, Baldassare JJ. J Biol Chem; 2004 Feb 13; 279(7):5387-96. PubMed ID: 14645251 [Abstract] [Full Text] [Related]
23. Signaling by ABL oncogenes through cyclin D1. Afar DE, McLaughlin J, Sherr CJ, Witte ON, Roussel MF. Proc Natl Acad Sci U S A; 1995 Oct 10; 92(21):9540-4. PubMed ID: 7568169 [Abstract] [Full Text] [Related]
24. Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase. Wang QM, Luo X, Kheir A, Coffman FD, Studzinski GP. Oncogene; 1998 May 28; 16(21):2729-37. PubMed ID: 9652739 [Abstract] [Full Text] [Related]
25. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins. Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D. Oncogene; 1999 May 06; 18(18):2798-810. PubMed ID: 10362250 [Abstract] [Full Text] [Related]
26. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway. Whittaker SR, Walton MI, Garrett MD, Workman P. Cancer Res; 2004 Jan 01; 64(1):262-72. PubMed ID: 14729633 [Abstract] [Full Text] [Related]
27. Ras inactivation of the retinoblastoma pathway by distinct mechanisms in NIH 3T3 fibroblast and RIE-1 epithelial cells. Pruitt K, Pestell RG, Der CJ. J Biol Chem; 2000 Dec 29; 275(52):40916-24. PubMed ID: 11007784 [Abstract] [Full Text] [Related]
28. The RB/p107/p130 phosphorylation pathway is not inhibited in rapamycin-induced G1-prolongation of NIH3T3 cells. Chen Y, Knudsen ES, Wang JY. Oncogene; 1996 Oct 17; 13(8):1765-71. PubMed ID: 8895523 [Abstract] [Full Text] [Related]
29. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Lukas J, Herzinger T, Hansen K, Moroni MC, Resnitzky D, Helin K, Reed SI, Bartek J. Genes Dev; 1997 Jun 01; 11(11):1479-92. PubMed ID: 9192874 [Abstract] [Full Text] [Related]
30. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation. Schoecklmann HO, Rupprecht HD, Zauner I, Sterzel RB. Kidney Int; 1997 Apr 01; 51(4):1228-36. PubMed ID: 9083291 [Abstract] [Full Text] [Related]
31. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Genes Dev; 1993 Mar 01; 7(3):331-42. PubMed ID: 8449399 [Abstract] [Full Text] [Related]
32. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement. Chen YY, Wang LC, Huang MS, Rosenberg N. Genes Dev; 1994 Mar 15; 8(6):688-97. PubMed ID: 7926759 [Abstract] [Full Text] [Related]
33. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells. Fiddes RJ, Janes PW, Sivertsen SP, Sutherland RL, Musgrove EA, Daly RJ. Oncogene; 1998 May 28; 16(21):2803-13. PubMed ID: 9652748 [Abstract] [Full Text] [Related]
34. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein. Hall FL, Williams RT, Wu L, Wu F, Carbonaro-Hall DA, Harper JW, Warburton D. Oncogene; 1993 May 28; 8(5):1377-84. PubMed ID: 8479754 [Abstract] [Full Text] [Related]
35. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts. Deininger MW, Vieira SA, Parada Y, Banerji L, Lam EW, Peters G, Mahon FX, Köhler T, Goldman JM, Melo JV. Cancer Res; 2001 Nov 01; 61(21):8005-13. PubMed ID: 11691826 [Abstract] [Full Text] [Related]
36. Down-regulation of the retinoblastoma protein (rb) is associated with rat oligodendrocyte differentiation. Huang Z, Tang XM, Cambi F. Mol Cell Neurosci; 2002 Feb 01; 19(2):250-62. PubMed ID: 11860277 [Abstract] [Full Text] [Related]
37. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Welch PJ, Wang JY. Cell; 1993 Nov 19; 75(4):779-90. PubMed ID: 8242749 [Abstract] [Full Text] [Related]
38. Prostaglandin A2 blocks the activation of G1 phase cyclin-dependent kinase without altering mitogen-activated protein kinase stimulation. Hitomi M, Shu J, Strom D, Hiebert SW, Harter ML, Stacey DW. J Biol Chem; 1996 Apr 19; 271(16):9376-83. PubMed ID: 8621603 [Abstract] [Full Text] [Related]
39. NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1. Yan GZ, Ziff EB. J Neurosci; 1995 Sep 19; 15(9):6200-12. PubMed ID: 7666202 [Abstract] [Full Text] [Related]
40. Rescue of defective mitogenic signaling by D-type cyclins. Roussel MF, Theodoras AM, Pagano M, Sherr CJ. Proc Natl Acad Sci U S A; 1995 Jul 18; 92(15):6837-41. PubMed ID: 7624328 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]